| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 2.45 Billion |
| Market Size (2030) | USD 6.69 Billion |
| CAGR (2025 - 2030) | 22.29 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Surrogacy Market Analysis
The Surrogacy Market size is estimated at USD 2.45 billion in 2025, and is expected to reach USD 6.69 billion by 2030, at a CAGR of 22.29% during the forecast period (2025-2030).
Key drivers propelling market expansion include increasing infertility rates, greater awareness of IVF treatments, enhanced understanding of assisted reproductive technologies such as IVF and surrogacy, and a rise in fertility clinics globally.
Infertility serves as a significant catalyst for the surrogacy market. The World Health Organization (WHO) reports that one in four couples in developing nations encounter infertility issues. Factors such as smoking, stress, diet, and obesity contribute to rising infertility rates, thereby driving the demand for surrogacy. WHO data from 2023 indicates that approximately 10% of women of reproductive age worldwide are affected by infertility, equating to about 48.5 million couples annually. Consequently, the increase in global infertility cases is expected to drive market growth.
Additionally, the growing number of single women and same-sex couples, along with increased awareness of IVF and surrogacy, are anticipated to further stimulate market growth. For instance, in August 2022, the Indian government introduced the Surrogacy (Regulation) Bill, which is set to become an Act. Despite some criticism for its restrictive nature, the bill aims to enhance transparency in India's surrogacy process. Similarly, in April 2024, India introduced new surrogacy guidelines that emphasize a more inclusive and compassionate approach to reproductive assistance. These guidelines aim to provide a structured framework for surrogacy arrangements while ensuring the rights and well-being of all parties involved.
Furthermore, in March 2024, the Fertility Conclave held in Delhi, India, brought together experts and stakeholders in the fertility industry. This conference provided a platform for discussing the latest innovations, advancements, and opportunities in infertility treatment and assisted reproductive technologies. Such initiatives and guidelines are anticipated to contribute to market growth.
Technological advancements in assisted reproductive techniques, such as IVF with ICSI (intracytoplasmic sperm injection), are offering viable solutions for those dealing with infertility and driving market growth. For instance, in January 2024, scientists from the University of California San Diego's School of Medicine developed a non-invasive method to improve the predictive capabilities for the quality of lab-generated embryos. This innovative approach focuses on identifying tiny fragments of genetic material (exRNAs) present in the liquid medium during the cultivation of embryonic cells. Such technological advancements are expected to increase adoption rates, contributing to market growth.
In summary, the global rise in infertility, coupled with evolving guidelines and technological innovations in fertilization techniques, is set to drive market growth. However, the high cost of treatment and stringent regulatory and ethical considerations are expected to hamper market growth.
Surrogacy Market Trends
In-Vitro Fertilization is Expected to Witness Healthy Growth During the Forecast Period
In-vitro fertilization (IVF) is poised for significant growth during the forecast period, driven by high procedural success rates and continuous advancements. The increasing number of IVF treatments has led more insurance providers to cover these procedures. According to the American Society of Reproductive Medicine in March 2023, the number of babies born from IVF increased from 89,208 in 2021 to 91,771 in 2022, representing 2.5% of all births in the United States. This rise in cycles indicates a strong demand for fertility services, despite challenging legislation and political threats. In the United States, IVF cycles at Society for Assisted Reproductive Technology member clinics increased by over 6%, from 368,502 in 2021 to 389,993 in 2022. This trend is expected to drive segment growth during the forecast period.
Government organizations are actively promoting awareness of IVF and its benefits. Some governments are offering financial assistance for surrogacy procedures, potentially increasing IVF's popularity as a primary infertility treatment. For instance, in March 2024, the Queensland government announced a USD 42.3 million package to help individuals who have experienced serious illnesses, such as cancer, access IVF treatment. Similarly, in August 2023, the Irish government allocated EUR 10 million (USD 10.85 million) to fund publicly funded IVF treatments. This initiative is expected to provide hope to many couples facing infertility and reshape the assisted reproductive technology landscape in the country. Government support for IVF treatment is anticipated to contribute to market growth during the forecast period.
In summary, the segment's growth is driven by rising infertility rates due to lifestyle changes and supportive government reimbursement policies.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold Significant Market Share Over the Forecast Period
North America holds a significant share of the surrogacy market due to increased awareness of infertility treatments, technological advancements, government initiatives promoting surrogacy facilities, and a rising number of infertility cases.
In the United States, the rise in infertility rates is expected to drive surrogacy demand, contributing to segment growth. Provisional estimates from March 2023 by the National Center for Health Statistics under the CDC reported approximately 3.6 million births, translating to 54.4 live births per 1,000 females aged 15 to 44. However, the fertility rate decreased by 3% from 2022. This sustained decline in U.S. fertility rates over the past decades highlights the growing demand for surrogacy, which supports market expansion.
Moreover, fertility tourism is on the rise, with individuals traveling abroad for treatments due to legal restrictions, lower costs, and technological advancements in destination countries. The United States, particularly California, is a popular surrogacy destination due to its favorable laws and high-quality reproductive technology. Increased access to treatments and insurance in the region further drives market growth. For instance, a public opinion poll by the American Society for Reproductive Medicine in April 2024 indicated strong support for expanding access to in-vitro fertilization (IVF). This supportive environment and proactive initiatives are expected to increase surrogacy demand, driving market growth.
In conclusion, factors such as high infertility rates, favorable government initiatives, increasing surrogacy tourism, and favorable IVF reimbursements are expected to propel market growth during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Surrogacy Industry Overview
The surrogacy market is fragmented with the presence of a large number of market players. The fertility clinics and hospitals are adopting key strategic activities, such as collaborations, acquisitions, and new platform launches, which may help in promoting surrogacy procedures among the population. Some of the key players in the market include IVI RMA Global, Houston Fertility Center, Ovation Fertility, Max Healthcare, and Clinic Scanfert.
Surrogacy Market Leaders
-
IVI RMA Global
-
Houston Fertility Center
-
Ovation Fertility
-
Max Healthcare
-
Clinic Scanfert
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Surrogacy Market News
- April 2024: Amrita Hospital, Kochi, India, launched a new Amrita Fertility Centre in Vyttila. The newly launched center offers a wide range of services, including in-vitro fertilization, intrauterine insemination, early cleavage, advanced fertility consultation and assessment, detailed sperm assessment, hystero-laparoscopic surgery, and fertility counseling.
- March 2024: Alife Health collaborated with Boston IVF, a renowned fertility clinic with over 25 locations nationwide, to spearhead the development of the country's first AI-driven tool for optimizing IVF medication.
Surrogacy Industry Segmentation
As per the scope of the report, surrogacy is an arrangement, often supported by a legal agreement, whereby a woman (the surrogate mother) agrees to bear a child for another person or persons who will become the child's parent(s) after birth.
The surrogacy market is segmented by type, technology, service providers, and geography. By type, the market is segmented as gestational surrogacy and traditional surrogacy. By technology, the market is segmented as intrauterine insemination (IUI), in-vitro fertilization, and other technologies. By service providers, the market is segmented into hospitals, fertility clinics, and other service providers. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The Report Offers the Value in USD for the Above Segments.
| By Type | Gestational Surrogacy | ||
| Traditional Surrogacy | |||
| By Technology | Intrauterine Insemination (IUI) | ||
| In-vitro Fertilization | Classic/Standard IVF | ||
| Intracytoplasmic Sperm Injection (ICSI) | |||
| Other Technologies | |||
| By Service Provider | Hospitals | ||
| Fertility Centers | |||
| Other Service Providers | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Surrogacy Market Research FAQs
How big is the Surrogacy Market?
The Surrogacy Market size is expected to reach USD 2.45 billion in 2025 and grow at a CAGR of 22.29% to reach USD 6.69 billion by 2030.
What is the current Surrogacy Market size?
In 2025, the Surrogacy Market size is expected to reach USD 2.45 billion.
Who are the key players in Surrogacy Market?
IVI RMA Global, Houston Fertility Center, Ovation Fertility, Max Healthcare and Clinic Scanfert are the major companies operating in the Surrogacy Market.
Which is the fastest growing region in Surrogacy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Surrogacy Market?
In 2025, the North America accounts for the largest market share in Surrogacy Market.
What years does this Surrogacy Market cover, and what was the market size in 2024?
In 2024, the Surrogacy Market size was estimated at USD 1.90 billion. The report covers the Surrogacy Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Surrogacy Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Surrogacy Industry Report
Statistics for the 2025 Surrogacy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Surrogacy analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
